Molecular UTI provides a reflex molecular phenotypic antibiotic susceptibility test that simultaneously identifies urinary pathogens and determines their true phenotypic resistance from a single specimen. By combining rapid genotypic identification with a proprietary phenotypic assay, the platform delivers actionable susceptibility results within hours, enabling clinicians to select targeted antibiotics and reduce unnecessary broad‑spectrum use. The solution is designed for clinical laboratories, hospital microbiology departments, and outpatient clinics seeking faster, more accurate UTI diagnostics.
Funding
Funding not disclosed
Founders
Product
Problem
Urinary tract infections are frequently treated empirically because conventional diagnostics either identify pathogens slowly or provide only genotypic resistance predictions, leading to inappropriate antibiotic use and delayed optimal therapy.
Solution
Molecular UTI offers a reflex molecular phenotypic antibiotic susceptibility test that simultaneously delivers pathogen identification and true phenotypic resistance profiling from the same specimen. The proprietary platform uses a rapid molecular workflow to detect the causative organism and then performs a phenotypic susceptibility assay on the identified pathogen, producing actionable susceptibility results in a single, streamlined process. By merging genotypic and phenotypic data, clinicians receive comprehensive, evidence‑based guidance faster than with separate culture‑based methods, enabling targeted antibiotic selection and reducing unnecessary broad‑spectrum prescribing.
Target Audience
Primary customers are clinical laboratories, hospital microbiology departments, and outpatient clinics that require rapid, accurate UTI diagnostics to guide antibiotic therapy.
Features
- Proprietary reflex method that triggers phenotypic susceptibility testing only after molecular identification of the specific uropathogen
- Combined genotypic identification and phenotypic antimicrobial susceptibility results in a single workflow
- Accelerated turnaround time compared with traditional culture, delivering actionable data within hours
- True phenotypic resistance profiling that captures mechanisms not detectable by genotype alone
- Single-sample processing compatible with existing clinical laboratory automation
- Optional at‑home urine collection kits to expand access for outpatient testing